PI
GNMK

Putnam Investments’s GenMark Diagnostics, Inc GNMK Stock Holding History

Putnam Investments’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,489,912
Closed -$25.7M – 1150
2018
Q3 		$25.7M Sell
3,489,912
-207,036
-6% -$1.52M 0.06% 235
2018
Q2 		$23.6M Sell
3,696,948
-710,100
-16% -$4.69M 0.05% 235
2018
Q1 		$24M Buy
4,407,048
+331,100
+8% +$1.65M 0.06% 241
2017
Q4 		$17M Sell
4,075,948
-768,411
-16% -$4.62M 0.04% 301
2017
Q3 		$46.7M Buy
4,844,359
+603,525
+14% +$6.27M 0.11% 168
2017
Q2 		$50.2M Buy
4,240,834
+136,283
+3% +$1.74M 0.12% 159
2017
Q1 		$52.6M Buy
4,104,551
+22,505
+0.6% +$271K 0.12% 166
2016
Q4 		$50M Sell
4,082,046
-494,377
-11% -$5.87M 0.12% 175
2016
Q3 		$54M Sell
4,576,423
-968,379
-17% -$9.35M 0.13% 171
2016
Q2 		$48.2M Sell
5,544,802
-505,347
-8% -$3.46M 0.12% 182
2016
Q1 		$31.9M Buy
6,050,149
+36,967
+0.6% +$206K 0.08% 228
2015
Q4 		$46.7M Buy
6,013,182
+11,820
+0.2% +$90.8K 0.11% 183
2015
Q3 		$47.2M Buy
6,001,362
+10,668
+0.2% +$98.7K 0.11% 192
2015
Q2 		$54.3M Sell
5,990,694
-186,689
-3% -$1.88M 0.11% 195
2015
Q1 		$80.2M Sell
6,177,383
-17,252
-0.3% -$226K 0.16% 140
2014
Q4 		$84.3M Sell
6,194,635
-10,935
-0.2% -$122K 0.17% 128
2014
Q3 		$55.7M Buy
6,205,570
+1,007,203
+19% +$10.8M 0.12% 172
2014
Q2 		$70.3M Buy
5,198,367
+28,366
+0.5% +$296K 0.15% 150
2014
Q1 		$51.4M Sell
5,170,001
-39,367
-0.8% -$489K 0.12% 188
2013
Q4 		$69.3M Buy
5,209,368
+363,627
+8% +$4.42M 0.17% 146
2013
Q3 		$58.9M Buy
4,845,741
+3,100,247
+178% +$33.2M 0.16% 159
2013
Q2 		$18M Buy
+1,745,494
New +$24.1M 0.05% 322

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Putnam Investments's GNMK Position: Q4 2018 in Review

Putnam Investments sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2018, closing a stake of 3,489,912 shares — an estimated $25.7M sold.

Putnam Investments first reported a position in GNMK in Q2 2013 and held it in 22 quarters. The position peaked at $84.3M in Q4 2014. 103 funds tracked by Wall St. Rank hold GNMK as of Q4 2018.

  • Putnam Investments reported no remaining GenMark Diagnostics, Inc position as of Q4 2018 after selling out during the quarter.
  • Putnam Investments sold 3,489,912 GenMark Diagnostics, Inc shares in Q4 2018, an estimated $25.7M.
  • Putnam Investments first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 22 quarters.
  • Putnam Investments's GenMark Diagnostics, Inc position peaked at $84.3M in Q4 2014.
  • 103 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2018.

Based on Putnam Investments's 13F filing for Q4 2018, filed 14 Feb 2019.